IASIOS Accreditation Program for Interventional Oncology Is Launched

April 26, 2021—The International Accreditation System for Interventional Oncology Services (IASIOS) announced it is now open for public enrollment after completing its pilot phase with 12 hospitals in nine countries. More information is available online at www.iasios.org.

According to IASIOS, its main goal is to establish the highest-quality standards in interventional oncology (IO) care throughout the entire service line and patient pathway. The system has been tested and optimized during the past 2 years and is now ready to accept applications from facilities offering IO services worldwide, regardless of the institution’s size or location.

IASIOS advised that with the continued growth and recognition of IO as an important clinical discipline, IO has become the fourth pillar of cancer care. Therefore, facilities providing IO therapies must follow appropriate guidelines if the relevant treatments are to be used safely and appropriately. Centers that enroll in the IASIOS system will become part of a greater worldwide community of top IO centers working together to further develop and promote the practice of IO and raise awareness of the benefits of this discipline among both patients and medical providers, noted the announcement.

As a blueprint for the accreditation system, IASIOS used the Standards of Quality Assurance in Interventional Oncology, published by the Cardiovascular and Interventional Radiological Society of Europe (CIRSE). This foundation will be instrumental in establishing the standardization of IO services on a global scale.

Professor Andreas Adam, MBBS, serves as Chairman of the IASIOS Supervisory Board. In the announcement, Prof. Adam commented, “IASIOS is the culmination of years of dedicated work by CIRSE. It is exciting to reach this stage, as this pioneering accreditation scheme will help improve cancer care around the world.”